Danaher Corporation

Investigation Alert BAX, DHR, BTAI, and IBRX: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below

Retrieved on: 
Tuesday, September 26, 2023
GMP, LLP, Institutional review board, Good manufacturing practice, Baxter International, CMOS, Record, DHR, Research, Danaher Corporation, Complaint, Dementia, Patient, FDA, Therapy, BLA, NYSE, Agitation, Food, Safety, Pharmaceutical industry, Management

Defendants’ failure to disclose Baxter’s true problems relating to its supply chain deceived investors about the Company’s true financial health and earnings.

Key Points: 
  • Defendants’ failure to disclose Baxter’s true problems relating to its supply chain deceived investors about the Company’s true financial health and earnings.
  • Johnson Fistel, LLP is investigating potential claims on behalf of Danaher Corporation (NYSE: DHR) against certain of its officers and directors.
  • Johnson Fistel, LLP is investigating potential claims on behalf of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) against certain of its officers and directors.
  • Johnson Fistel, LLP is investigating potential claims on behalf of ImmunityBio, Inc. (NASDAQ: IBRX) against certain of its officers and directors.

FreshRealm Strengthens Its Leadership Position as the Complete Fresh Meal Solution Company with New Leadership Roles and Expanded Distribution Channels

Retrieved on: 
Monday, September 25, 2023
DTC, Blue Apron, Dr Pepper Snapple Group, Snow, Danaher Corporation, Acquisition, SAN, VC, Management, Food delivery

SAN CLEMENTE, Calif., Sept. 25, 2023 /PRNewswire/ -- FreshRealm, the leading national omnichannel fresh meals platform, announced today it has appointed Snow Le as President to lead the day-to-day operations, specifically focusing on scaling the company's business systems structure for long-term success. With the addition of Le to the executive team, Michael Lippold, Founder & CEO, will focus time on building strategic partnerships and expanding corporate development efforts.

Key Points: 
  • Following the transfer of Blue Apron's operational infrastructure to FreshRealm earlier this year[1], the company has continued to strengthen its meal platform across multiple distribution channels with a broad and efficient solutions offering.
  • With these new roles, FreshRealm is well positioned to address the $46 billion market opportunity[2] for fresh prepared meals.
  • With capabilities across all fresh and prepared meal types – ready to heat, ready to cook and meal kits, FreshRealm has developed a unique omnichannel solution to serve customers ranging from grocery, convenience, club, meal DTC companies, medical meal providers and other growing meal segments.
  • "I am excited to join the executive team and help grow and scale the organization to meet the growing customer demand across all channels of distribution."

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, RPT, SMMF

Retrieved on: 
Thursday, September 21, 2023
Danaher Corporation, Abcam, Kimco Realty, Fraud, RPT Realty, NYSE, Advertising, RPT, Sale, Security (finance)

If you are an Abcam shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are an Abcam shareholder, click here to learn more about your rights and options .
  • RPT Realty (NYSE: RPT)’s sale to Kimco Realty for 0.6049 of a newly-issued Kimco share for each RPT share.
  • Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected] .
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – THRN, ABCM, RPT, SMMF

Retrieved on: 
Monday, September 18, 2023
Kimco Realty, Danaher Corporation, Abcam, Empire, Sale, Monteverde, RPT Realty, NYSE, RPT, Security (finance)

Under the terms of the agreement, THRN shareholders are expected to receive $10.20 in cash per share they own.

Key Points: 
  • Under the terms of the agreement, THRN shareholders are expected to receive $10.20 in cash per share they own.
  • Under the terms of the agreement, ABCM shareholders are expected to receive $24.00 in cash per share they own.
  • Summit Financial Group, Inc. (Nasdaq: SMMF ), relating to its proposed merger with Burke & Herbert Financial Services Corp.
  • Under the terms of the agreement, SMMF shareholders are expected to own 50% of the combined company.

Global Chemiluminescence Immunoassay Industry Research Report 2023: Increasing Incidence of Diseases and Technological Advancements to Drive Market Expansion to 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, September 20, 2023
Infectious Diseases, Biotechnology, Health, HIV/AIDS, Endocrinology, Hepatitis, Blood, Gastroenterology, Urinary tract infection, HIV, Chemiluminescence, Infection, Abbott Laboratories, Cancer, Hepatitis B, DSM-IV codes, Danaher Corporation, DiaSorin, Incidence, Instrument, Toxicology, Consumables, Growth, Bone mineral, Cardiology, WHO, HBV, Neurology, Syphilis, Saliva, Malaria, Phosphorus, Pharmaceutical industry, Urine

The "Global Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global chemiluminescence immunoassay market, valued at approximately USD 13.2 billion in 2023, is expected to experience significant growth, reaching USD 19.0 billion by 2028, with a notable CAGR of 7.5%.
  • This comprehensive report provides valuable insights for both established market leaders and newcomers, offering precise revenue estimations for the overall market and its subsegments.
  • Oncology testing segment is expected to grow at the highest rate within the chemiluminescence immunoassay market.

Laboratory Centrifuge Market size to grow by USD 360.98 million from 2022-2027 | Azer Scientific Inc., Accumax Lab Devices Pvt. Ltd. and Agilent Technologies Inc. are some of the leading companies - Technavio

Retrieved on: 
Friday, September 22, 2023
Benchmark, Centurion, Countertop, QIAGEN, Corning Inc., Hospital, Medication, Danaher Corporation, Inwood Laboratories, Inc. v. Ives Laboratories, Inc., Sartorius AG, Cardinal Health, USD, Agilent Technologies, Thermo Fisher Scientific, Laboratory, ROW, SE, Growth, HOB GmbH & Co KG, Laboratory centrifuge, Pharmaceutical industry, Online shopping, Biotechnology, Geography

Companies are implementing various strategies like forming partnerships, mergers, expanding into new areas, and launching new products to improve their market position.

Key Points: 
  • Companies are implementing various strategies like forming partnerships, mergers, expanding into new areas, and launching new products to improve their market position.
  • The report also offers detailed analyses of the market's competitive landscape, featuring information on leading companies including Azer Scientific Inc., Accumax Lab Devices Pvt.
  • View Free PDF Sample Report
    Driver - The laboratory centrifuge market is experiencing growth, largely due to the popularity of online distribution channels.
  • Trend - The laboratory centrifuge market is experiencing growth driven by the emergence of next-generation centrifuge systems, known as smart centrifuges.

Danaher to Provide Cepheid's Tuberculosis Test to the Global Fund at Cost

Retrieved on: 
Tuesday, September 19, 2023
Partnership, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Bill & Melinda Gates Foundation, TB, Danaher, DHR, Infection, Research, International development, Danaher Corporation, Mark R. Dybul, Incidence, AIDS, Patient, Tuberculosis, United, Stop TB Partnership, USAID, NYSE, World Health Organization, Pharmaceutical industry, Video game, Unitaid, Malaria, Cepheid variable

Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher.

Key Points: 
  • Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher.
  • WASHINGTON, Sept. 19, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology innovator, today announced it will provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for tuberculosis (TB) at Cepheid's cost of $7.97 each to the Global Fund to Fight AIDS, TB and Malaria ("the Global Fund") and to less-developed countries eligible for Cepheid's Global Access Program1 to support greater access to high-quality TB testing.
  • By reducing the price of Cepheid's Xpert® MTB/RIF Ultra test cartridge to $7.97, Danaher will be selling at its cost and will earn no profit.
  • The agreement significantly expands a longtime partnership between Cepheid - a Danaher operating company - and the Global Fund to improve access to testing where it matters most.

Abcam plc Statement on Dr. Jonathan Milner’s Announcement

Retrieved on: 
Thursday, September 14, 2023
Biotechnology, Health, Science, Pharmaceutical, Research, Justice, Disclosure, Danaher, High court, Danaher Corporation, Telephone numbers in Hungary, High Court of Justice, Acquisition, Lazard, Takeover, Confusion, Security (finance), Abcam

Abcam plc (Nasdaq: ABCM) (“Abcam” or the “Company”), notes today’s announcement by Dr. Jonathan Milner.

Key Points: 
  • Abcam plc (Nasdaq: ABCM) (“Abcam” or the “Company”), notes today’s announcement by Dr. Jonathan Milner.
  • All bidders were given access to the same financial information, consistent with the information the Company has made public.
  • After receiving offers from multiple bidders, Danaher’s all cash offer of $24.00 was the highest and best price.
  • Abcam is not a company subject to regulation under the City Code on Takeovers and Mergers (the “UK Takeover Code”), therefore no dealing disclosures are required to be made under Rule 8 of the UK Takeover Code by shareholders of Abcam or Danaher.

Water Quality Sensor Market to increase by USD 1.58 billion from 2022 to 2027, Increasing focus on Monitoring the Water Quality in the industrial sector to Drive Growth - Technavio

Retrieved on: 
Friday, September 15, 2023
Estuary, Urbanization, ABB, Food, Petroleum, Drinking water, Water pollution, Aquaculture, Water quality, Water, Danaher Corporation, Research, Temperature, Recycling, YOY, FREE, USD, Drinking, Gesellschaft mit beschränkter Haftung, ORP, PPP, Flood, Thermo Fisher Scientific, Nature, Chlorine, Siemens, Investment, River, Groundwater, Disinfectant, Growth, Geography, Water resources, Population growth, Wetland, Sewage treatment

NEW YORK, Sept. 14, 2023 /PRNewswire/ -- The water quality sensor market size is expected to grow by USD 1.58 billion from 2022 to 2027.

Key Points: 
  • NEW YORK, Sept. 14, 2023 /PRNewswire/ -- The water quality sensor market size is expected to grow by USD 1.58 billion from 2022 to 2027.
  • Increasing focus on monitoring the water quality in the industrial sector is a key factor driving market growth.
  • In addition, utilities are finding it difficult to manage water distribution due to increasing water scarcity and rising energy costs.
  • The report analyses the market size and growth and provides accurate predictions on the growth of the market.

Ormco Announces the Launch of its Latest Innovation - Ormco™ Digital Bonding, Powered by Spark™ Technology

Retrieved on: 
Thursday, September 14, 2023
Orthodontics, Workflow, Rotation, Torque, Patient, Software, Dentistry, Danaher Corporation

BREA, Calif., Sept. 14, 2023 /PRNewswire/ -- Ormco Corporation today announces the launch of Ormco Digital Bonding (OBD).

Key Points: 
  • Key features of Ormco Digital Bonding include:
    Damon Ultima Brackets, the first true full-expression orthodontic system designed for faster and more precise finishing.
  • Now with Ormco Digital Bonding, Ormco has leveraged its premiere orthodontic solutions to provide orthodontists with even greater flexibility, more treatment options and an overall trouble-free workflow.
  • "Our latest example is Ormco Digital Bonding which combines the best of our orthodontic solutions in brackets and aligners.
  • To learn more about Ormco Digital Bonding and to Request a Demo, visit https://go-orm.co/odbdigitalbonding .